Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1259261

Boston Research & Management Inc

Wealth managerFiled 2026-08-11 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$452.6M
Reported positions
121
Top holdings a year, 3 yrs
+15.4%
Assets under management
$676.2M

Boston Research & Management Inc is a wealth manager that reported 121 positions worth $452.6M in its Q2 2026 13F, filed 2026-08-11. Its largest holdings were Ishares Tr (IVV, 4.8%), Alphabet Inc (GOOGL, 3.4%), Cisco Sys Inc (CSCO, 3.2%). A portfolio copying its top holdings returned 15.4% a year over the last 3 years, against 20.4% for the S&P 500.

Boston Research & Management Inc holdings largest 50 of 121 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Boston Research & Management Inc 13F holdings
Stock% of 13F valueShare changeReported value
IVVIshares Tr4.8%-0.7%$21.6M
GOOGLAlphabet Inc3.4%-1.6%$15.5M
CSCOCisco Sys Inc3.2%-1.4%$14.5M
AAPLApple Inc3.1%-1.1%$14.2M
MSFTMicrosoft Corp3.0%+0.3%$13.8M
WMTWalmart Inc2.7%-2.2%$12.2M
ABBVAbbvie Inc2.7%-0.5%$12.1M
IJRIshares Tr2.5%-0.6%$11.2M
JPMJpmorgan Chase & Co2.3%-0.5%$10.5M
FASTFastenal Co2.1%-0.7%$9.6M
BNYBank of Ny Mellon Corp2.0%-1.2%$9.2M
BRK-BBerkshire Hathaway Inc Del1.9%-1.7%$8.7M
MAMastercard Incorporated1.9%-0.9%$8.5M
MRKMerck & Co Inc1.9%-1.1%$8.5M
IEMGIshares Inc1.8%-2.5%$8.3M
LINLinde PLC1.8%-0.9%$8.1M
AMZNAmazon Com Inc1.8%-0.6%$8.0M
NVDANvidia Corporation1.7%-1.5%$7.7M
XOMExxon Mobil Corp1.6%-0.5%$7.2M
SNASnap on Inc1.6%-1.2%$7.1M
PGProcter & Gamble Co1.5%+0.2%$6.9M
XYLXylem Inc1.5%+1.6%$6.7M
IEFAIshares Tr1.5%-1.4%$6.6M
DHID R Horton Inc1.4%-0.6%$6.5M
LHLabcorp Holdings Inc1.4%-0.2%$6.5M
MCDMcdonalds Corp1.4%-0.4%$6.5M
NEENextera Energy Inc1.4%-0.3%$6.5M
KOCoca Cola Co1.3%-0.6%$6.0M
LLYEli Lilly & Co1.3%+0.0%$5.8M
DUKDuke Energy Corp New1.3%-0.2%$5.8M
SYYSysco Corp1.3%+1.2%$5.7M
LMTLockheed Martin Corp1.3%+0.1%$5.7M
USBUS Bancorp1.3%-1.2%$5.7M
CLColgate Palmolive Co1.2%-0.3%$5.5M
012653200Albemarle Corp1.2%—$5.5M
TMOThermo Fisher Scientific Inc1.2%+1.5%$5.5M
IWMIshares Tr1.2%-2.5%$5.4M
ABTAbbott Laboratories1.2%-0.3%$5.4M
TSCOTractor Supply Co1.2%-0.1%$5.4M
SPYState Str Spdr S&p 500 ETF T1.1%-0.5%$5.2M
LOWLowes Cos Inc1.1%—$5.0M
PEPPepsico Inc1.0%+1.2%$4.6M
VZVerizon Communications Inc1.0%+0.4%$4.6M
DISDisney Walt Co1.0%-1.6%$4.6M
VTIVanguard Index Fds1.0%+0.0%$4.6M
UPSUnited Parcel Svcs Inc1.0%-0.2%$4.6M
COPConocophillips0.9%-0.5%$4.3M
EQIXEquinix Inc0.9%-0.9%$4.2M
MDTMedtronic PLC0.9%+1.3%$4.0M
XLESelect Sector Spdr Tr0.9%-0.4%$4.0M

What Boston Research & Management Inc bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

No position grew by more than 5%.

Reduced

No position shrank by more than 5%.

Left the top 50

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+14.8% /yr
S&P 500 +20.1%
3 years
+15.4% /yr
S&P 500 +20.4%
5 years
+9.1% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$452.6M121
Q1 2026$421.0M114
Q4 2025$433.7M120
Q3 2025$453.4M119
Q2 2025$418.4M116
Q1 2025$402.7M116
Q4 2024$407.4M115
Q3 2024$425.7M115
Q2 2024$395.5M113
Q1 2024$404.6M115
Q4 2023$376.7M113
Q3 2023$338.3M114

Questions about Boston Research & Management Inc's portfolio

What stocks does Boston Research & Management Inc own?

Boston Research & Management Inc's latest 13F, for Q2 2026 and filed Aug 11, 2026, lists 121 positions worth $452.6M. The largest are Ishares Tr (IVV) at 4.8%, Alphabet Inc (GOOGL) at 3.4%, Cisco Sys Inc (CSCO) at 3.2%, Apple Inc (AAPL) at 3.1% and Microsoft Corp (MSFT) at 3.0%.

What did Boston Research & Management Inc buy last quarter?

Boston Research & Management Inc opened no new positions and grew none by more than 5% among its largest holdings in Q2 2026.

What did Boston Research & Management Inc sell last quarter?

In Q2 2026, Boston Research & Management Inc cut from its top 50 Ishares Gold Tr (IAU) and cut from its top 50 General Mills Inc (GIS), compared with its Q1 2026 filing.

How has Boston Research & Management Inc's portfolio performed?

A portfolio copying Boston Research & Management Inc's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.4% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +14.8% against +20.1%. Over 5 years: +9.1% a year against +11.6%.

When is Boston Research & Management Inc's next 13F filing due?

13F filings are due 45 days after each quarter ends. Boston Research & Management Inc's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Boston Research & Management Inc manage?

Boston Research & Management Inc reported $676.2M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $452.6M.